glp-1 obesity drug news today Study flags need to monitor frailty risks with drugs for older adults Popular GLP-1 medications may have

[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Sodhi M., Rezaeianzadeh R., Kezouh A., Etminan M

illegally and used by some compounding pharmacies to create copycat versions of branded GLP-1s

This could be attributed to the different mechanisms of action of these two drugs

Differences between GLP1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcomes, mean there may be benefits to switching from one to another

"The effect of fatty diacid acylation of human PYY 3-36 on Y 2 receptor potency and half-life in minipigs"

Additional concerns surround DPP-4 inhibitors and their interference with immune function